» Articles » PMID: 27434277

Outbreak of Achromobacter Xylosoxidans and Ochrobactrum Anthropi Infections After Prostate Biopsies, France, 2014

Overview
Date 2016 Jul 20
PMID 27434277
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

We report an outbreak of healthcare-associated prostatitis involving rare environmental pathogens in immunocompetent patients undergoing transrectal prostate biopsies at Hôpital Édouard Herriot (Lyon, France) during August 13-October 10, 2014. Despite a fluoroquinolone-based prophylaxis, 5 patients were infected with Achromobacter xylosoxidans and 3 with Ochrobactrum anthropi, which has not been reported as pathogenic in nonimmunocompromised persons. All patients recovered fully. Analysis of the outbreak included case investigation, case-control study, biopsy procedure review, microbiologic testing of environmental and clinical samples, and retrospective review of hospital records for 4 years before the outbreak. The cases resulted from asepsis errors during preparation of materials for the biopsies. A low-level outbreak involving environmental bacteria was likely present for years, masked by antimicrobial drug prophylaxis and a low number of cases. Healthcare personnel should promptly report unusual pathogens in immunocompetent patients to infection control units, and guidelines should explicitly mention asepsis during materials preparation.

Citing Articles

The in vitro synergistic and antibiofilm activity of Ceftazidime/avibactam against Achromobacter species recovered from respiratory samples of cystic fibrosis patients.

Mataraci-Kara E, Damar-Celik D, Ozbek-Celik B Eur J Clin Microbiol Infect Dis. 2024; 44(3):587-596.

PMID: 39702543 DOI: 10.1007/s10096-024-05017-0.


Metabarcoding using nanopore sequencing enables identification of diverse and zoonotic vector-borne pathogens from neglected regions: A case study investigating dogs from Bhutan.

Huggins L, Namgyel U, Wangchuk P, Atapattu U, Traub R, Colella V One Health. 2024; 19:100839.

PMID: 39005237 PMC: 11238191. DOI: 10.1016/j.onehlt.2024.100839.


Achromobacter cluster related to COVID-19 supply chain issues.

Scales M, Gallagher M, Haessler S, Lindsey K, Maryanski M, Mathew M Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e67.

PMID: 38698950 PMC: 11062781. DOI: 10.1017/ash.2024.66.


Genomics of (newly named ) reveals a new subgroup.

Li S, Huang Y, Chen J, Lai C, Mao Y, Huang Y Microb Genom. 2021; 7(8).

PMID: 34448692 PMC: 8549353. DOI: 10.1099/mgen.0.000626.


The Genus as Major Opportunistic Pathogens.

Ryan M, Pembroke J Microorganisms. 2020; 8(11).

PMID: 33207839 PMC: 7696743. DOI: 10.3390/microorganisms8111797.


References
1.
Galosi A, Muzzonigro G, Lacetera V, Mazzucchelli R . Specimen orientation by marking the peripheral end: (potential) clinical advantages in prostate biopsy. Prostate Cancer. 2011; 2011:270403. PMC: 3200280. DOI: 10.1155/2011/270403. View

2.
Dumford 3rd D, Suwantarat N, Bhasker V, Kundrapu S, Zabarsky T, Drawz P . Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate. Infect Control Hosp Epidemiol. 2013; 34(3):269-73. DOI: 10.1086/669512. View

3.
Christenson J, Pavia A, Seskin K, Brockmeyer D, Korgenski E, Jenkins E . Meningitis due to Ochrobactrum anthropi: an emerging nosocomial pathogen. A report of 3 cases. Pediatr Neurosurg. 1998; 27(4):218-21. DOI: 10.1159/000121256. View

4.
Liss M, Johnson J, Porter S, Johnston B, Clabots C, Gillis K . Clinical and microbiological determinants of infection after transrectal prostate biopsy. Clin Infect Dis. 2014; 60(7):979-87. DOI: 10.1093/cid/ciu1129. View

5.
Olshtain-Pops K, Block C, Temper V, Hidalgo-Grass C, Gross I, Moses A . An outbreak of achromobacter xylosoxidans associated with ultrasound gel used during transrectal ultrasound guided prostate biopsy. J Urol. 2010; 185(1):144-7. DOI: 10.1016/j.juro.2010.08.093. View